Antiplatelet Agents in Endovascular Neurointerventional Procedures.

Area of Science:

• Neurology
• Cardiology
• Interventional Radiology

Background:

• Minimally invasive, image-guided endovascular procedures, especially neurointerventions, are increasingly common.
• These procedures carry a risk of endothelial injury, leading to thromboembolic complications.
• Managing antiplatelet therapy is crucial due to the dual risk of thromboembolic and hemorrhagic complications.

Purpose of the Study:

• To review the mechanisms of action, clinical indications, and management of antiplatelet agents in neurointerventional procedures.
• To highlight the current variability in clinical practice and the need for standardization.

Main Methods:

• Focused review of existing literature and clinical consensus on antiplatelet therapy in neurointerventions.
• Discussion of antiplatelet agent mechanisms and their application in periprocedural settings.

Main Results:

• Clinical consensus supports the use of periprocedural antiplatelet agents for improved patient outcomes.
• Current practices for antiplatelet use are highly variable across institutions and practitioners.

Conclusions:

• Antiplatelet agents are vital in managing patients undergoing endovascular neurointerventions.
• Further research is required to establish standardized, procedure-specific antiplatelet regimens and monitoring protocols.